about
Life Expectancy in Patients Treated for Osteoporosis: Observational Cohort Study Using National Danish Prescription Data.Romosozumab and blosozumab: alternative drugs of mechanical strain-related stimulus toward a cure for osteoporosisA Comprehensive Fracture Prevention Strategy in Older Adults: The European Union Geriatric Medicine Society (EUGMS) Statement.Bone mineral content and areal density, but not bone area, predict an incident fracture risk: a comparative study in a UK prospective cohortThe use of bisphosphonates in women: when to use and when to stop.Goal-Directed Treatment for Osteoporosis: A Progress Report From the ASBMR-NOF Working Group on Goal-Directed Treatment for Osteoporosis.Zoledronic Acid (Reclast®, Aclasta®): A Review in Osteoporosis.Value of a coordinated management of osteoporosis via Fracture Liaison Service for the treatment of orthogeriatric patients.Fracture prediction from repeat BMD measurements in clinical practice.Assessment of Fracture Risk in A Population of Postmenopausal Italian Women: A Comparison of Two Different Tools.Spanish consensus on treat to target for osteoporosis.Screening for osteoporosis following non-vertebral fractures in patients aged 50 and older independently of gender or level of trauma energy-a Swiss trauma center approach.Fracture risk assessment in postmenopausal women with diabetes: comparison between DeFRA and FRAX tools.Bone Turnover Status: Classification Model and Clinical Implications.New and emerging concepts in the use of denosumab for the treatment of osteoporosis
P2860
Q30890172-E72E523E-DEF6-4B73-954D-7090B53887C6Q35507830-7268A62E-D41D-4283-9EF3-1204C3B68D05Q37392405-EE3DFEEA-5875-4020-8213-0EC8A182A818Q37588135-252D1FC3-7A18-4A7F-82D6-B1476A1EB9E2Q38584336-B067B4BD-4994-45C9-AA96-8EBE17C6B35BQ38793382-A2CA76B1-85BF-4E72-9D14-B8C46A96FA3CQ39013796-54590F52-714B-4DB3-9D57-216CADC96766Q39560135-CFF21649-CB52-48ED-A3AE-A66C071C45F3Q40659866-E9420FB9-E460-4E7B-8B9F-B3D263931F9CQ40978391-B626148B-3F87-411C-9D22-2A33E3BFFD2BQ47596255-B837642D-F41E-45C9-B641-C107B48DD586Q47799402-1A3ECC27-AFDA-45B2-A409-B9A3698C5FB8Q49667245-32D16F51-3864-4E50-83FF-C0AD0E1A525EQ55002406-C41430E5-3124-489B-93B6-7FC8D0B04675Q58583955-028C8F4C-0A16-4FA5-A5E0-7F14A4E5C05C
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Goal-directed treatment of osteoporosis in Europe.
@en
type
label
Goal-directed treatment of osteoporosis in Europe.
@en
prefLabel
Goal-directed treatment of osteoporosis in Europe.
@en
P2093
P2860
P1476
Goal-directed treatment of osteoporosis in Europe.
@en
P2093
E Dennison
E McCloskey
J-M Kaufman
J-P Devogelaer
J-Y Reginster
M-L Brandi
P2860
P2888
P304
P356
10.1007/S00198-014-2787-1
P407
P577
2014-09-09T00:00:00Z
P6179
1020892121